Cadrenal Therapeutics CMO James Ferguson resigns, effective July 31
CVKD•Chief Medical Officer resignation
Cadrenal Therapeutics Chief Medical Officer James J. Ferguson III resigned, effective July 31, 2026.
The board was notified on July 7, 2026.
A search is underway for a replacement.
Separation terms are being negotiated, with a separation agreement and release planned.




